This site is intended for healthcare professionals

Venclexta + chemotherapy improved overall survival in VIALE-A study with patients with previously untreated acute myeloid leukemia. - Genentech /Roche

Read time: 1 mins
Published:24th Mar 2020
Condition: Acute Myelogeous Leukemia (AML)
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest